Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Codexis has announced the signing of a collaboration and license agreement with Takeda for the research and development of novel gene therapies for certain disease indications.
read more
Codexis and Alphazyme announced a Co-Marketing & Enzyme Supply Collaboration Agreement for the production and co-marketing of enzymes for life science applications.
read more
Codexis and Nestlé Health Science have signed an agreement to advance a lead candidate discovered through a SCA into preclinical development and early clinical studies.
read more
Thursday, October 29, 2026
Codis has completed demolition and begun construction on an expansion at its Haverhill, United Kingdom, site that will add commercial-scale spray drying capacity for pharmaceutical manufacturing.
read more
Codis has completed its acquisition of Catalent’s Nottingham, UK facility, a move that expands the company’s integrated spray dry offering in Europe and adds oral solid dose development and small-scale commercial manufacturing capabilities.
read more
Wednesday, March 04, 2026
Codis announced a major expansion of its UK manufacturing capabilities with the purchase of a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer. Codis will become the only UK CDMO offering this capacity. The addition will take place at its 400,...
read more
Tuesday, October 14, 2025
Codis, a newly established contract development and manufacturing organization (CDMO), has entered the pharmaceutical outsourcing market with a focus on commercial-scale spray drying and amorphous solid dispersion technologies.
read more
Codis has agreed to acquire Catalent Pharma Solutions’ Nottingham, UK facility, adding oral solid dose development and small-scale manufacturing capabilities to its contract development and manufacturing operations.
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Thursday, November 01, 2018
Lannett has approved a plan to sell Cody Laboratories, a subsidiary that produces active pharmaceutical ingredients (API) used in prescription pain medications.
read more
Friday, November 08, 2019
Cognate BioServices and Cobra Biologics have entered into a definitive agreement in which Cognate will acquire all of the outstanding share capital of Cobra.
read more
Cognate BioServices, a contract development and manufacturing organization in the global cellular therapies industry, has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW ...
read more
Wednesday, January 20, 2021
Cobra Biologics, the gene therapy division of the Cognate BioServices’ group, has announced a multi-phase augmentation of its plasmid DNA services as a continuation of its Gene Therapy services’ expansion project for viral vectors and plasmid DNA.
read more
Wednesday, November 04, 2020
Cognita Labs announced the FDA has issued clearance for PulmoScan, a home-usable lung assessment device that measures airway resistance and elastance.
read more
Wednesday, January 20, 2016
Cognition Life Science, Inc. has selected Smart Science Laboratories Inc. as an FDA/GMP manufacturer for the production of its product for sleep disorders.
read more